Ferriprox ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2
120	遺伝性ジストニア	3

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-003679-31-ES (EUCTR)	21/03/2016	13/01/2016	New therapeutic strategy in Parkinson?s disease	Conservative iron chelation as a disease-modifying strategy in Parkinson?s disease: a multicentre, p ...	De Novo Parkinson?s disease MedDRA version: 18.1;Level: PT;Classification code 10061536;Term: Parkin ...	Trade Name: Ferriprox 500 mg Product Name: Deferiprone DR INN or Proposed INN: DEFERIPRONE	Centre Hospitalier Régional et Universitaire de Lille	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	338	Phase 3	Spain
2	EUCTR2011-001148-31-GB (EUCTR)	13/09/2011	17/08/2011	A pilot clinical trial with the iron chelator Deferiprone in Parkinson's disease - Pilot clinical tr ...	A pilot clinical trial with the iron chelator Deferiprone in Parkinson's disease - Pilot clinical tr ...	Parkinson's disease	Trade Name: Ferrprox (Deferiprone) Product Name: Deferiprone (Ferriprox) INN or Proposed INN: Deferipr ...	Imperial College London	NULL	Not Recruiting			Female: yes Male: yes	48	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United Kingdom

First Previous1Next Last

120. 遺伝性ジストニア

臨床試験数 : 26 / 薬物数 : 19 - (DrugBank : 3) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 2

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-001427-79-GB (EUCTR)	30/12/2015	05/11/2015	An international open label trial of deferiprone in patients with iron storage brain disorders - an ...	Long-term Safety and Efficacy Study of Deferiprone in Patients with Pantothenate Kinase-Associated N ...	Pantothenate Kinase-Associated Neurodegeneration (PKAN) MedDRA version: 18.1;Level: PT;Classificatio ...	Trade Name: Ferriprox Product Name: Deferiprone 80 mg/mL oral solution INN or Proposed INN: Deferipron ...	ApoPharma Inc	NULL	Not Recruiting	Female: yes Male: yes	89	Phase 3	United States;Germany;Italy;United Kingdom
2	EUCTR2012-000845-11-GB (EUCTR)	24/10/2013	19/09/2013	An international trial of deferiprone in patients with iron storage brain disorders	A randomized, double-blind, placebo-controlled trial of deferiprone in patients with pantothenate ki ...	Pantothenate Kinase-Associated Neurodegeneration (PKAN) MedDRA version: 16.0;Level: PT;Classificatio ...	Trade Name: Ferriprox Product Name: Deferiprone 80 mg/mL oral solution (Ferriprox) INN or Proposed INN ...	ApoPharma Inc	NULL	Not Recruiting	Female: yes Male: yes	90	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Poland;Germany;Italy;United Kingdom
3	EUCTR2008-003059-56-IT (EUCTR)	29/07/2008	18/07/2008	Phase II trial to assess safety and efficacy of Iron chelating agent Deferiprone in patients with Pa ...	Phase II trial to assess safety and efficacy of Iron chelating agent Deferiprone in patients with Pa ...	PKAN MedDRA version: 9.1;Level: HLT;Classification code 10042259;Term: Structural brain disorders NE ...	Trade Name: FERRIPROX*100CPR RIV 500MG INN or Proposed INN: Deferiprone	ISTITUTO NEUROLOGICO CARLO BESTA	NULL	Not Recruiting	Female: yes Male: yes		Phase 2	Italy

First Previous1Next Last

先頭へ